• LAST PRICE
    164.6600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    159.3500/ 1
  • Ask / Lots
    188.5400/ 1
  • Open / Previous Close
    0.0000 / 164.6600
  • Day Range
    ---
  • 52 Week Range
    Low 159.7300
    High 245.0000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 166.03
TimeVolumeKRTX
09:32 ET2091164.65
09:34 ET610164.815
09:36 ET100164.71
09:39 ET100163.565
09:41 ET100162.07
09:45 ET517162.98
09:50 ET900163.37
09:52 ET100163.315
09:59 ET200163.02
10:01 ET1421164.15
10:03 ET500163.89
10:06 ET100163.81
10:08 ET131163.93
10:10 ET100163.59
10:14 ET300163.62
10:28 ET2130163.49
10:33 ET1213163.155
10:35 ET600163.785
10:37 ET100163.48
10:39 ET200163.265
10:42 ET1000162.61
10:44 ET100162.64
10:51 ET100162.61
10:53 ET1800163.34
10:57 ET100163.14
11:00 ET300163.2
11:02 ET400163.375
11:04 ET2900163.23
11:06 ET2300163.76
11:08 ET1300163.6
11:09 ET1510163.43
11:11 ET1000163.07
11:13 ET1000163.525
11:15 ET400163.705
11:18 ET300163.5
11:20 ET100163.53
11:22 ET300163.53
11:24 ET200163.53
11:26 ET1300163.44
11:27 ET200163.465
11:29 ET100163.32
11:31 ET600163.44
11:33 ET500163.2457
11:36 ET200163.45
11:38 ET200163.38
11:42 ET600163.355
11:44 ET1909163.4
11:47 ET308163.02
11:54 ET400163.53
11:56 ET200163.5
11:58 ET100163.4225
12:00 ET130163.34
12:02 ET675163.485
12:03 ET600163.26
12:05 ET100163.35
12:14 ET300163.16
12:16 ET400163.42
12:18 ET637163.3875
12:20 ET100163.5
12:21 ET200163.32
12:25 ET100163.23
12:27 ET200163.505
12:32 ET457163.42
12:34 ET2245162.93
12:36 ET100163.31
12:39 ET300163
12:41 ET400163.25
12:43 ET200163.45
12:45 ET100163.295
12:50 ET868163.405
12:56 ET500163.5
12:57 ET4012163.44
12:59 ET2950164.57
01:01 ET1400165.54
01:06 ET2924164.985
01:10 ET500165.155
01:14 ET100165.41
01:15 ET400165.585
01:17 ET611165.41
01:21 ET100165.43
01:24 ET600165.02
01:28 ET300164.55
01:32 ET400164.94
01:35 ET100164.78
01:37 ET100164.78
01:39 ET897164.8
01:42 ET800164.68
01:46 ET800164.36
01:48 ET200164.21
01:50 ET400164.34
01:55 ET300164.055
01:57 ET100164.06
02:04 ET100164.015
02:08 ET100163.855
02:09 ET500163.78
02:11 ET100163.81
02:13 ET100163.76
02:18 ET300163.75
02:20 ET100163.3
02:22 ET110163.89
02:24 ET100163.43
02:27 ET800163.71
02:36 ET1170163.43
02:44 ET500163.45
02:47 ET300163.52
02:51 ET200163.35
02:54 ET1100163.26
02:58 ET21229163.36
03:00 ET1363163.495
03:02 ET12306163.57
03:05 ET500163.75
03:09 ET476163.63
03:12 ET100163.385
03:16 ET700163.81
03:18 ET2980164.005
03:20 ET872163.31
03:21 ET300163.825
03:23 ET100163.56
03:27 ET4880164.22
03:30 ET217163.73
03:32 ET300163.9
03:34 ET1066164.04
03:36 ET300164.525
03:38 ET150164.41
03:39 ET100164.44
03:41 ET300164.38
03:43 ET200164.48
03:45 ET1804165.11
03:48 ET2430165.2
03:50 ET300164.98
03:52 ET800164.76
03:54 ET1421164.94
03:56 ET1639164.93
03:57 ET3450164.57
03:59 ET35983164.66
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKRTX
Karuna Therapeutics Inc
6.2B
-16.2x
---
United StatesRETA
Reata Pharmaceuticals Inc
6.6B
-57.7x
---
United StatesASND
Ascendis Pharma A/S
5.5B
-8.3x
---
United StatesAPLS
Apellis Pharmaceuticals Inc
5.1B
-7.4x
---
United StatesPCVX
Vaxcyte Inc
4.8B
-15.3x
---
United StatesITCI
Intra-Cellular Therapies Inc
5.2B
-28.0x
---
As of 2023-09-26

Company Information

Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its pipeline is primarily built on the therapeutic potential of its product candidate, KarXT (xanomeline-trospium), an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS), and various peripheral tissues. KarXT combines xanomeline, a novel muscarinic agonist, with trospium, an approved muscarinic antagonist, to preferentially stimulate muscarinic receptors in the CNS. The Company is developing KarXT for the treatment of acute psychosis in adults with schizophrenia, as well as for the treatment of psychosis in Alzheimer's disease (AD). The Company is also engaged in developing its investigational TRPC4/5 candidate, KAR-2618, for the treatment of mood and anxiety disorders, and plan to provide details regarding the expected development of KAR-2618.

Contact Information

Headquarters
99 High Street, 26Th FloorBOSTON, MA, United States 02110
Phone
857-449-2244
Fax
302-636-5454

Executives

Independent Chairman of the Board
Christopher Coughlin
President, Chief Executive Officer, Director
William Meury
Chief Financial Officer
Troy Ignelzi
Chief Operating Officer
Andrew Miller
Chief Human Resource Officer
Jonathan Rosin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.2B
Revenue (TTM)
$6.0M
Shares Outstanding
37.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.09
EPS
$-10.15
Book Value
$32.67
P/E Ratio
-16.2x
Price/Sales (TTM)
1,031.5
Price/Cash Flow (TTM)
---
Operating Margin
-6,569.15%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.